Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1996
03/07/1996CA2198479A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition
03/07/1996CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
03/07/1996CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198362A1 Topical anti-inflammatory composition and method
03/07/1996CA2198080A1 Cell cycle regulated repressor and dna element
03/07/1996CA2196063A1 Cosolvent parenteral formulation of tirilazad
03/07/1996CA2195874A1 Aerosol drug formulations containing polyglycolyzed glycerides
03/06/1996EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4
03/06/1996EP0699439A2 Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
03/06/1996EP0699436A1 Controlled release formulation
03/06/1996EP0699433A2 Cosmetic or pharmaceutical composition containing chitosan derivatives
03/06/1996EP0699432A1 Cosmetic and/or dermatologic composition containing thermal or mineral water and an active agent against acnee or ageing
03/06/1996EP0699079A1 Bioactive and/or targeted dendrimer conjugates
03/06/1996EP0670714A4 Retinoic acid-containing compositions.
03/06/1996EP0630231B1 Liposomes with excess negative charge
03/06/1996EP0395653B1 Synovial phospholipases
03/06/1996CN1118168A Structured copolymers used as absorbents, gels and carriers of metal ions
03/06/1996CN1118160A Polyamine derivatives as radioprotective agents
03/06/1996CN1118143A Excipient stabilization of polypeptides treated with organic solvents
03/06/1996CN1118136A Methods for in vivo delivery of biologics and compositions useful therefor
03/06/1996CN1117875A Composition consisting of a dendrimer and an active substance occluded in the dendrimer, a process for the preparation of such a composition and a process for releasing the active substance
03/06/1996CN1117874A Nasally administrable compositions
03/06/1996CN1117851A Yinhuang Lozenge and its preparation method
03/05/1996US5496934 Nucleic acids encoding a cellulose binding domain
03/05/1996US5496827 Compositions for the transdermal delivery of nutrients
03/05/1996US5496819 Drug delivery
03/05/1996US5496809 Of water, 8-n-(diethylaminoethyl)rebeccamycin and a pharmaceutically acceptable acid
03/05/1996US5496801 Storage stability, mannitol, citric acid buffer
03/05/1996US5496567 Vitamin supplements
03/05/1996US5496565 Microspherules
03/05/1996US5496564 Suspendible composition and process for preparing the same
03/05/1996US5496563 Dry gel composition
03/05/1996US5496561 Time-release agents for drugs from membrane layers of polymers
03/05/1996US5496558 Solid form xerostomia product
03/05/1996US5496557 Wall is composed of two degradable polymers, one permeable to active substance, the other poorly permeable; polymers are poly/ortho/esters, poly-alpha-amino acids, polydepsipeptides, polyanhydrides, polyphosphazenes, copolymers, stereo complexes
03/05/1996US5496549 Bispecific monoclonal antibodies, thrombolytic agent and method of cell lysis
03/05/1996US5496545 Phosphate-binding polymers for oral administration
03/05/1996US5496535 Gas generating agent, improved palatability, magnetic resonance imaging
03/05/1996US5496471 Apparatus for removing components from solutions
03/05/1996CA2010022C Anesthetic oral compositions
02/1996
02/29/1996WO1996006116A1 Immunoconjugates comprising tyrosine kinase inhibitors
02/29/1996WO1996006114A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells
02/29/1996WO1996005865A1 Combination immunotoxin/antineoplastic agent therapy for b-lineage cancer
02/29/1996WO1996005864A1 Solid pharmaceutical form for the administration of a liposoluble liquid active substance
02/29/1996WO1996005863A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use
02/29/1996WO1996005857A1 Device for delivery of substances and methods of use thereof
02/29/1996WO1996005843A1 Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol
02/29/1996WO1996005842A1 Intravenous alendronate formulations
02/29/1996WO1996005834A1 Improved pharmaceutical formulations containing ibuprofen and codeine
02/29/1996WO1996005815A1 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives
02/29/1996WO1996005814A1 Oestradiol transdermal therapeutic system comprising hygroscopic additives
02/29/1996WO1996005812A1 Hydrophilic controlled release device
02/29/1996WO1996005810A1 Drug delivery composition containing chitosan or derivative thereof having a defined z. potential
02/29/1996WO1996005809A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof
02/29/1996WO1996001128A3 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets
02/29/1996WO1995032735A3 Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease
02/29/1996DE4430601A1 Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander Cell adhesion peptides to modify the adhesion behavior of eukaryotic cells between each other
02/29/1996DE4429747A1 Cosmetic ointment and cream bases
02/29/1996CA2198207A1 Cell adhesion peptides for use in modifying mutual adhesion among eukaryotic cells
02/29/1996CA2197577A1 Immunoconjugates comprising tyrosine kinase inhibitors
02/29/1996CA2188948A1 Device for delivery of substances and methods of use thereof
02/28/1996EP0698393A1 Solubilizing agent and external preparation containing the same
02/28/1996EP0698389A1 Controlled release matrix for pharmaceuticals
02/28/1996EP0698113A1 Production of toxin binding biopolymers, use thereof
02/28/1996EP0698109A1 Gene transfer into pancreatic and biliary epithelial cells
02/28/1996EP0698040A1 Lhrh antagonists
02/28/1996EP0698018A1 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use
02/28/1996EP0697891A1 Polyoxime compounds and their preparation
02/28/1996EP0697890A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
02/28/1996EP0697889A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
02/28/1996EP0697887A1 Stable liquid compositions of gamma interferon
02/28/1996EP0697881A1 New cyclosporine-containing pharmaceutical compositions for oral administration
02/28/1996EP0697874A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
02/28/1996EP0697867A1 Compositions in the form of solid solutions
02/28/1996EP0697866A1 High dose formulations
02/28/1996EP0697860A1 Transdermal therapeutic system containing estradiol
02/28/1996EP0697859A1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions
02/28/1996EP0697858A1 Nasal drug delivery composition containing nicotine
02/28/1996EP0697821A1 Cholesterol lowering drink mix compositions
02/28/1996EP0661966A4 Ulcer prevention and treatment composition and method.
02/28/1996EP0630644A4 Anti-microbial and interferon-inducing pharmaceutical compound.
02/28/1996EP0588897B1 Non-chlorofluorocarbon aerosol formulations
02/28/1996EP0572502A4 Polyamino acid dispersants
02/28/1996EP0547126B1 Biodegradable polymers containing diester units
02/28/1996EP0533836B1 Reversible gelation compositions and methods of use
02/28/1996CN1117383A Cefixime composition
02/27/1996US5494938 Comprisinga water insoluable oil, alkyl glucosides and fatty acid glycerides; storage stability, homogeneity
02/27/1996US5494936 Delivery formulation for probucol
02/27/1996US5494901 Includes carbonic anhydrase inhibitor
02/27/1996US5494683 Surface modified anticancer nanoparticles
02/27/1996US5494682 Encapsulated biomass in crosslinked polymer material
02/27/1996US5494681 Molten blend of active material, spatially oriented matrix comprising wax core material, hydrophobic polymer
02/27/1996US5494680 Transdermal delivery device
02/27/1996US5494679 Molecules for iontophoretic delivery
02/27/1996US5494665 Metal chloride, lysozyme chloride, isotonic agent, nonionic thickening agent and preservative
02/27/1996CA2170505A1 Compositions and methods for the administration of .delta.-aminolevulinic acid and pharmaceutical equivalents thereof
02/27/1996CA2030204C Pharmaceutical compositions of tebufelone
02/24/1996CA2156768A1 Pharmaceutical formulations, their preparation and use
02/22/1996WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase